Drug profile · INN
dextromethorphan polistirex
DEXTROMETHORPHAN POLISTIREX
dextromethorphan polistirex (DEXTROMETHORPHAN POLISTIREX) is a sigma opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — dextromethorphan polistirex
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
dextromethorphan polistirex (DEXTROMETHORPHAN POLISTIREX) is a sigma opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sigma opioid receptor agonist
Primary target: Glutamate receptor ionotropic, NMDA 2A
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dextromethorphan polistirex?
dextromethorphan polistirex (DEXTROMETHORPHAN POLISTIREX) is a sigma opioid receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dextromethorphan polistirex?
DEXTROMETHORPHAN POLISTIREX is a marketed brand name for dextromethorphan polistirex. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dextromethorphan polistirex?
dextromethorphan polistirex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.